Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma.

Trial Profile

Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Temsirolimus (Primary) ; Cisplatin; Cyclophosphamides; Doxorubicin; Etoposide; Irinotecan; Isotretinoin; Topotecan
  • Indications Neuroblastoma
  • Focus Adverse reactions
  • Most Recent Events

    • 19 May 2010 Actual patient number (4) added as reported by ClinicalTrials.gov.
    • 19 May 2010 Planned end date changed from 1 Dec 2012 to 1 Oct 2014 as reported by ClinicalTrials.gov.
    • 19 May 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top